금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Somali Piracy Surges Amid Hormuz Blockade
The effective closure of the Strait of Hormuz has forced hundreds of commercial ships onto longer ro...
Silver Price Forecast: XAG stalls as yields cap recovery
Silver price advanced by some 0.39% on Friday, capped by rising US yields, even though US data was s...
GLD vs SLV: Gold Stability Versus Silver Momentum
Silver delivered 65.5% returns in one year but with triple gold's drawdown risk. Which bullion fund suits your portfolio?
Warren Buffett Has Recommended 1 Investment for Decades -- but There's a Hidden Risk Many Investors Are Overlooking
This key factor didn't exist when Buffett first gave the advice, but does that change its appeal?
Exchange-Traded Funds Decline as US Equities Fall After Midday
Broad Market Indicators Broad-market exchange-traded funds IWM and IVV fell. Actively traded I
Central banks plan first U.S. dollar decline in 3 years; Gold & Euro winning
Lockheed Martin, Rheinmetall plan first ATACMS missile production in Europe
The Stock Market Is Doing Better Than It Looks
The big three stock market indexes are down, but it’s not as bad as it looks. The Dow was down 150 points, or 0.3%. Low volatility and value stocks were leading the market, while momentum, growth, a ...
12 stocks favored to soar in the sector that has missed the 2026 market rally
The S&P 500’s consumer discretionary sector is the only one of 11 sectors to decline so far this year.
Why GE Vernova, Caterpillar Stocks Are Getting Crushed
A Wall Street downgrade of Siemens Energy has sparked a sell of in shares of power generation equipment providers.
Rivian’s stock sale triggers worst rout for the shares in nearly two years
Rivian’s stock is down 13% as Wall Street frets about the EV maker’s cash troubles.
Midday Need to Know: Rivian falls, Trump revives Greenland bid and more
Top Midday Stories: Amazon Seeking at Least $25 Billion From US Bond Sale; Fiserv Explores Sale of STAR Debit Network
All three major US stock indexes were down in late-morning trading Tuesday, with the Nasdaq Composit
Kailera falls after late-stage trial data for oral GLP-1 candidate